Security record · archived quarter
PRAX
Praxis Precision Medicines, Inc. · Healthcare · Biotechnology
12Tracked holders
0Δ holders
3.95MShares held
$227.16MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -3.4% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +10 | 16.57M | $5.55B | +16 | −5 |
| Q1 2026 | 103 | +2 | 17.55M | $5.65B | +11 | −10 |
| Q4 2025 | 101 | +1 | 18.04M | $5.32B | +2 | — |
| Q3 2025 | 17 | +1 | 10.82M | $573.60M | +1 | −1 |
| Q2 2025 | 14 | 0 | 8.51M | $357.72M | +1 | −1 |
| Q1 2025 | 11 | -2 | 4.62M | $175.13M | — | −2 |
| Q4 2024 | 13 | 0 | 4.07M | $313.25M | — | — |
| Q3 2024 | 12 | 0 | 3.95M | $227.16M | +1 | −1 |
| Q2 2024 | 12 | — | 4.09M | $168.97M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 1.12M | +19.3% | $64.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 1.12M | +19.3% | $64.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Point72 Asset Management ✦ | 1.03M | -1.8% | $59.45M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 854.08K | -24.7% | $49.14M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 398.84K | +1.0% | $22.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 398.84K | +1.0% | $22.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 219.91K | +326.9% | $12.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 219.91K | +326.9% | $12.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 219.91K | +326.9% | $12.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 219.91K | +326.9% | $12.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 170.09K | -31.5% | $9.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 170.09K | -31.5% | $9.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 48.03K | +112.1% | $2.76M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 48.03K | +112.1% | $2.76M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 46.36K | +120.0% | $2.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 46.36K | +120.0% | $2.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 25.27K | New | $1.45M | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 25.27K | New | $1.45M | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 25.27K | New | $1.45M | 0.0% | New | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 22.77K | -5.0% | $1.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Norges Bank ✦ (passive) | 5.00K | -84.4% | $287,700 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 4.17K | -95.4% | $239,884 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $1.45M | 0.0% |
| AQR Capital Management | $1.45M | 0.0% |
| AQR Capital Management | $1.45M | 0.0% |
Exited
| Renaissance Technologies | $3.12M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 287 holders, 28.34M shares, $8.85B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API